• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Venus Remedies Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
526953
INE411B01019
515.9180123
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VENUSREM
24.25
2407.73
EPS(TTM)
Face Value()
Div & Yield %
74.29
10
0.56
 

Board of Hikal recommends final dividend
May 28,2026
Hikal announced that the Board of Directors of the Company at its meeting held on 27 May 2026, inter alia, have recommended the final dividend of Rs 0.4 per equity Share (i.e. 20%) , subject to the approval of the shareholders.